Cortex Pharmaceuticals Inc.: The Irvine drug development...

Cortex Pharmaceuticals Inc.: The Irvine drug development company recorded a net loss of $1.3 million, or 17 cents a share, for the second fiscal quarter, compared with a net loss of $1.1 million, or 17 cents a share, for the corresponding prior-year period. The net loss for the first half totaled $2.5 million, or 33 cents a share, compared with a net loss of $2 million, or 33 cents a share, for the first six months a year ago. No revenue was reported.